|
Pharmacological Group: Antineoplastics, Active Ingredient: Asparaginase, Pharmaceutical Form: Lyophile Powder, Concentration / Dosage: 10,000, Unit: Iu, Volume: N/A, Presentation: Vial-Ampule, Accessory: N/A, Pharmacological Group: Adjuvant Therapy, Active Ingredient: Finasteride, Pharmaceutical Form: Tablet, Concentration / Dosage: 5, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Antianemics, Active Ingredient: Folinic Acid, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 50 Mg, Presentation: Ampoule Bottle, Active Ingredient: Ifosfamide, Concentration / Dosage: 1, Unit: G, Active Ingredient: Pegaspargase, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 750, Unit: U/Ml, Volume: 5 Ml, Supply Form: Unit, 04/22/2026 - 10:34:35, Active Ingredient: Rituximab, Concentration / Dosage: 100, Volume: 10 Ml, Concentration/Dosage: 500, Volume: 50 Ml
|
